Abstract:Objective: To establish the model of non-alcoholic fatty liver (NAFL) in mice and isolate morphologically sound and biologically active kupffer cells (KCs) based on the improved hepatic perfusion digestion method, so as to study the function of phenotypic changes of kupffer cells in NAFL. Methods: C57BL/6J male mice were classified into the control group and the high-fat-diet group. The mice were observed after being fed for 12 weeks. Their serum hepatic indexes were detected, and fixed hepatic tissues were made into pathological sections. Some liver tissues were taken to detect the serum concentration of ALT, AST, TC, TG according to the serum ALT, AST, TC, TG assay kit instructions. Mice KCs were isolated by improved perfusion digestion method, and the isolated KCs were identified by ED1 immunocytochemical staining. The ratio changes of the types of cells (CD11b+ and CD68+) in mice with non-alcoholic fatty liver were detected by means of the flow cytometer. The expression level of TNF-α, CD-14, IL-6 and TLR-4 protein of primary KCs in the mice with non-alcoholic fatty liver disease were detected by the Western blot. Results: The serum concentration of TG, AST, TC, TG in mice in the high-fat-diet group were significantly higher than that of the control group (P<0.05). Compared with the control group, the proportion level of the two types of (CD11b+CD68+ and CD11b+CD68-) cells in the the process of establishing non-alcoholic fatty liver model significantly changed, and the ratio of CD11b+CD68cells increased. The Western blot assay results showed that compared with the control group, the expression level of TNF-α, CD-14, IL-6 and TLR-4 protein in primary KCs of the mice in the high-fat-diet group were significantly increased (P<0.05). Conclusion: Kupffer cells (KCs) transferred to CD68-CD11+ in the occurrence and development of NAFL, which may promote the further progression of NAFL by elevating the pro-inflammatory cytokines.

Research progress of relationship between Kupffer cells and non-alcoholic fatty liver disease

Role of Kupffer cell in non-alcoholic fatty liver disease

Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions

Major roles of kupffer cells and macrophages in NAFLD development

Function and Therapeutic Advances of Chemokine and Its Receptor in Nonalcoholic Fatty Liver Disease

Comprehensive Understanding of Immune Cells in the Pathogenesis of Non-alcoholic Fatty Liver

Research Progress on the Mechanism of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Oxidative Stress

Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: from Basic Science to Clinical Trials

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

The Latest Research Progress of Non-alcoholic Fatty Liver Disease-related Hepatocellular Carcinoma

Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy

Research Progress on Non-Alcoholic Fatty Liver Disease

Progress in role of hepatic macrophages in the pathogeny of alcoholic fatty liver disease

Research on the function of carotenoids in non-alcoholic fatty liver disease

[Study on the Phenotype Changes of Kupffer Cells in Non-Alcoholic Fatty Liver].

Research progress on gut microbial ecology in the pathogenesis of nonalcoholic fatty liver disease

Roles of Kupffer Cell Polarization and Hepatic Stellate Cell Activation in Hepatic Inflammation and Fibrosis in NAFLD

Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis

The relationship between curcumin and non-alcoholic fatty liver disease

Roles of Kupffer cells in homeostatic maintenance and differentiation and maturation of liver NK cell subsets

Pathogenesis and Research Progress of Nonalcoholic Fatty Liver Disease/nonalcoholic Steatohepatitis